Could A New Wave Of Nerve Stimulation Technology Transform Chronic Pain Care At Home?

Medtronic’s planned $650 million acquisition of SPR Therapeutics has shone a global spotlight on temporary peripheral nerve stimulation, a minimally invasive, drug-free approach to chronic pain that could hold significant implications for community health services and home-based care across the UK. Continue reading Could A New Wave Of Nerve Stimulation Technology Transform Chronic Pain Care At Home?

TechTransforming Parkinson’s Disease Treatment in 2026

Every twenty minutes, someone in the UK is diagnosed with Parkinson’s disease, yet treatment progress has historically moved slowly, built on decades-old drugs and incremental surgical advances. That is now changing, with major UK-led trials and emerging technologies signalling a rapid shift in how the condition may be detected, monitored, and treated. Continue reading TechTransforming Parkinson’s Disease Treatment in 2026